CJC 1295

COA CJC-1295, Ipamorelin  (No DAC) (Peptide Blend)Certificate

CJC 1295 is a synthetic peptide designed to increase growth hormone (GH) production by stimulating the pituitary gland. As a GHRH (Growth Hormone Releasing Hormone) analog, it promotes sustained GH and IGF-1 secretion, making it a popular option in both anti-aging and performance-enhancement protocols.

Unlike traditional GHRH peptides, CJC 1295 is modified with Drug Affinity Complex (DAC) technology, extending its half-life to approximately one week. This allows for less frequent dosing and more stable plasma GH levels over time, contributing to improved recovery, fat metabolism, muscle growth, and sleep quality.

HPLC CJC-1295, Ipamorelin  (No DAC) (Peptide Blend)Certificate

MSCJC-1295, Ipamorelin  (No DAC) (Peptide Blend)Certificate

 

Ipamorelin 10mg

Ipamorelin 10mg is a synthetic peptide classified as a growth hormone secretagogue. It mimics the body’s natural ghrelin to stimulate the release of growth hormone (GH) from the pituitary gland without affecting cortisol, prolactin, or other hormone levels — making it one of the cleanest and most selective GH-releasing peptides available.

Favored in both anti-aging and athletic performance protocols, Ipamorelin supports lean muscle development, fat reduction, improved sleep, and faster recovery from injury or training. Its mild side effect profile and strong safety margin make it a preferred option in long-term wellness and research applications.

Key Features:

• Stimulates natural growth hormone release
• Promotes fat loss and lean muscle gains
• Enhances sleep quality and recovery
• Minimal impact on other hormones (e.g., cortisol or prolactin)
• Well-tolerated and selective GH secretagogue

Mechanism of Action:
Ipamorelin binds to ghrelin receptors in the pituitary gland, triggering pulsatile GH release without the unwanted spikes in hunger or adrenal hormones associated with other peptides like GHRP-6 or GHRP-2.

Use & Storage:
For research purposes only. Store lyophilized powder in a cool, dry place. Once reconstituted, refrigerate and use within a limited timeframe based on manufacturer or lab guidance.

 Ipamorelin  CJC 1295 Dosage

The combination of Ipamorelin and CJC-1295 is widely used in research to stimulate the body’s natural growth hormone (GH) production through dual action. While CJC 1295 extends the duration of GH release by acting as a GHRH analog, Ipamorelin triggers potent, pulse-like releases of GH without impacting other hormones like cortisol or prolactin. Together, they offer synergistic benefits in fat loss, muscle building, recovery, and anti-aging.

Common Research Dosage Guidelines:

Typical Research Protocol:

• Dosage:
  • CJC-1295 (with DAC): 1–2 mg per week (single injection)
  • CJC-1295 (without DAC): 100 mcg 1–2x daily
  • Ipamorelin: 100–300 mcg 1–2x daily
• Injection Timing:
  • Administer subcutaneously, preferably on an empty stomach
  • Common timing: post-workout or before bedtime to align with natural GH pulses
• Cycle Duration:
  • 8–12 weeks on, followed by a 2–4 week break

Combination Benefits:

• Enhanced and sustained GH release
• Improved fat metabolism and lean muscle retention
• Better sleep, skin quality, and recovery
• No significant impact on appetite, cortisol, or prolactin levels

This combo is often preferred for its balance of effectiveness, safety, and low side effect risk compared to other peptide stacks.

FAQs CJC 1295  Ipamorelin 10mg

1. What is CJC-1295  Ipamorelin 10mg?
CJC-1295 + Ipamorelin 10mg is a combination peptide therapy designed to stimulate natural growth hormone (GH) release. CJC-1295 increases the duration of GH secretion, while Ipamorelin triggers GH pulses. Together, they promote muscle growth, fat loss, better recovery, and improved sleep.

2. How does this combination work?
CJC-1295 (a GHRH analog) prolongs GH release by stimulating the pituitary gland, while Ipamorelin (a selective GHRP) initiates rapid GH bursts. This synergistic action supports sustained and amplified growth hormone levels without disrupting other hormones like cortisol.

3. What is the typical research dosage?

• CJC-1295 (no DAC): 100 mcg 1–2x daily
• Ipamorelin: 100–300 mcg 1–2x daily
• Inject subcutaneously, often pre-bed or post-exercise for optimal results.
  Note: CJC-1295 with DAC is typically dosed at 1–2 mg once per week.

4. What are the potential benefits?

• Increased lean muscle mass
• Reduced body fat
• Improved sleep and recovery
• Enhanced skin tone and elasticity
• Anti-aging support via higher GH and IGF-1 levels

5. Are there side effects?
Side effects are generally mild and may include temporary injection site irritation, water retention, or slight headaches. Unlike other peptides, Ipamorelin does not significantly elevate cortisol, prolactin, or hunger.

6. How long should a typical cycle last?
Research cycles often last 8–12 weeks, followed by a 2–4 week break. Long-term use should be supervised and adjusted based on results and tolerance.

7. Can this combo be used for anti-aging purposes?
Yes. The combination is often explored in age-management protocols due to its ability to restore more youthful GH levels without harsh side effects.

8. Is this product suitable for human use?
This product is for research purposes only unless prescribed by a licensed healthcare professional. It is not approved by the FDA for general use.

9. How should it be stored?

• Store the lyophilized (dry) vial in a cool, dry place
• Once reconstituted, keep refrigerated and use within the recommended timeframe

10. Why use the combination instead of each peptide alone?
The combination amplifies both the strength and duration of GH release. While either peptide offers benefits on its own, together they deliver a more effective and balanced GH secretion profile with minimal hormonal disruption.